Human papillomavirus type 16 minor capsid protein L2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm

Journal of Virology

Volumn 75, Issue 5, 2001, Pages 2331-2336

  Kawana, Y ^a   Kawana, K ^a   Yoshikawa, H ^a   Taketani, Y ^a   Yoshiike, K ^a   Kanda, T ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CAPSID PROTEIN; EPITOPE; PROTEIN L2; SYNTHETIC PEPTIDE; TRYPSIN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; DISEASE PREDISPOSITION; EPITHELIUM CELL; FLOW CYTOMETRY; GENE CONSTRUCT; HUMAN; HUMAN CELL; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; VIRION; VIROGENESIS; VIRUS ADSORPTION; VIRUS CAPSID; VIRUS INFECTION; VIRUS VIRULENCE; WART VIRUS;

AMINO ACID SEQUENCE; ANIMALS; CAPSID; CAPSID PROTEINS; COS CELLS; EPITOPES; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; LUMINESCENT PROTEINS; MOLECULAR SEQUENCE DATA; MUTATION; NEUTRALIZATION TESTS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RECOMBINANT FUSION PROTEINS; TUMOR VIRUS INFECTIONS; VIRION;

EID: 0035130055     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.5.2331-2336.2001     Document Type: Article

References (27)

1. A peptide encoding a B-cell epitope from the N-terminus of the capsid protein L2 of bovine papillomavirus-4 prevents disease
2. Green fluorescent protein as a marker for gene expression
3. Vaccination of cattle with the N-terminus of L2 is necessary and sufficient for preventing infection by bovine papillomavirus-4
4. The open reading frame L2 of cottontail rabbit papillomavirus contains antibody-inducing neutralizing epitopes
5. 6 integrin as a candidate receptor for papillomaviruses
6. Vaccination of cattle with bovine papillomavirus type 4 L2 elicits the production of virus-neutralizing antibodies
7. Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins
8. A surface immunodeterminant of human papillomavirus type 16 minor capsid protein L2
9. In vitro construction of pseudovirions of human papillomavirus type 16: Incorporation of plasmid DNA into reassembled L1/L2 capsids
10. Common neutralization epitope in minor capsid protein L2 of human papillomaviruses 16 and 6
11. Papillomavirus L1 major capsid protein salf-assembles into virus-like particles that are highly immunogenic
12. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles
13. Effective vaccination against papilloma development by immunization with L1 or L2 structural protein of cottontail rabbit papillomavirus
14. Human papillomavirus infection of the cervix; relative risk associations of 15 common anogenital types
15. 6 integrin confers papillomavirus binding upon receptor-negative B-cells
16. Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA
17. Papillomavirus capsid binding and uptake by cells from different tissues and species
18. Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins
19. In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype
20. Interaction of papillomaviruses with the cell surface
21. Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes
22. Expression of human papillomavirus type 11 L1 protein in insect cells: In vivo and in vitro assembly of viruslike particles
23. α6 Integrin is not the obligatory cell receptor for bovine papillomavirus type 4
24. Generation and neutralization of pseudovirions of human papillomavirus type 33
25. Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells
26. Papillomavirus infections - A major cause of human cancers
27. Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis